多维认知训练在脑胶质瘤术后认知障碍患者早期康复中的应用
该单中心、评估者盲法、非随机对照试验纳入兰州某三级医院神经外科收治的脑胶质瘤伴认知障碍患者,比较多维认知训练(MCT)联合标准康复与单纯标准康复的效果。
要点
- MCT联合标准康复可改善脑胶质瘤术后认知障碍患者的整体认知功能(MoCA交互效应p<0.001)。
- 干预组焦虑(SAS交互p<0.001)与抑郁(SDS交互p<0.01)较对照组显著下降。
- 生活质量QLQ-C30交互效应p=0.002,12周组间差异p=0.035。
核心结论
- MCT可增强脑胶质瘤认知障碍患者的认知功能、减轻焦虑抑郁并改善生活质量,可能通过心理调节、环境适应和认知重塑实现。
研究设计与样本
- 单中心、评估者盲法、非随机对照试验,2024年1月至2025年1月在兰州某三级医院神经外科开展,按病房分组为干预组(MCT+标准康复)与对照组(仅标准康复)。
- 在基线(T1)、4周(T2)和12周(T3)采用MoCA、EORTC QLQ-C30、SAS和SDS评估,数据分析采用重复测量方差分析和广义估计方程。
主要发现
- 整体认知功能MoCA时间×组交互p<0.001,12周组间差异p=0.001。
- 特定认知域(注意、语言、记忆和定向)均p<0.05。
- 焦虑SAS交互p<0.001;抑郁SDS交互p<0.01;4周和12周组间差异均p<0.05。
- 生活质量QLQ-C30时间×组交互p=0.002,12周组间差异p=0.035。
临床怎么用
- 对脑胶质瘤术后伴认知障碍患者,可在标准康复基础上早期联合多维认知训练以改善认知、情绪与生活质量。
局限性
- 为非随机对照试验,按病房分组可能引入选择偏倚。
- 试验为回顾性注册(ClinicalTrials.gov NCT06327048,2024年2月29日注册)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the effects of a Multidimensional Cognitive Training (MCT) program on cognitive function, quality of life, and anxiety, depression symptoms among glioma patients experiencing cognitive impairment. METHODS: A single-center, assessor-blinded, non-randomized controlled trial was conducted from January 2024 to January 2025 among glioma patients with cognitive impairment admitted to the neurosurgery department of a tertiary hospital in Lanzhou. Eligible participants were assigned to an intervention group (MCT plus standard rehabilitation care) or a control group (standard rehabilitation care only) based on their hospital ward. The MCT program was developed through expert consensus. Cognitive function (Montreal Cognitive Assessment [MoCA]), health-related quality of life (EORTC QLQ-C30), anxiety (Self-Rating Anxiety Scale [SAS]), and depression (Self-Rating Depression Scale [SDS]) were measured at baseline (T1), 4 weeks (T2), and 12 weeks (T3). Data were analyzed using repeated-measures ANOVA and generalized estimating equations. RESULTS: Sixty-nine patients completed the study (intervention group: n = 36; control group: n = 33), with no significant baseline differences. Compared with controls, the intervention group showed greater gains in global cognitive function (MoCA: time × group interaction, p < 0.001; 12-week difference, p = 0.001) and specific cognitive domains (attention, language, memory, and orientation; all p < 0.05). Anxiety and depression also decreased significantly (SAS: interaction, p < 0.001; SDS: interaction, p < 0.01; between-group differences at 4 and 12 weeks, p < 0.05). Health-related quality of life (QLQ-C30: time × group interaction, p = 0.002; between-group difference at 12 weeks, p = 0.035). CONCLUSION: MCT enhanced cognitive function, reduced anxiety and depression, and improved quality of life in glioma patients with cognitive impairment, likely through psychological regulation, environmental adaptation, and cognitive remodeling. TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov (Identifier: NCT06327048) February 29, 2024. The trial was retrospectively registered.
引用
- Ma Y, Zhou R, Ma Y, et al. Application of multidimensional cognitive training in the early postoperative period for glioma patients with cognitive impairment. J Neurooncol. 2026. PMID: 42043588. doi:10.1007/s11060-026-05575-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。